Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$497,295
+$21,067 QoQ
Shares Held
3,870
-2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,702
of 3,768 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. MRK ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,295 | 3,870 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $476,228 | 3,959 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $404,303 | 3,841 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $303,742 | 3,619 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $280,463 | 3,543 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $306,799 | 3,418 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $421,098 | 4,233 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $417,673 | 3,678 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $458,555 | 3,704 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $472,908 | 3,584 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $392,035 | 3,596 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $380,606 | 3,697 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $422,442 | 3,661 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $384,280 | 3,612 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $450,457 | 4,060 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $314,424 | 3,651 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $324,656 | 3,561 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $287,749 | 3,507 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $262,185 | 3,421 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $270,396 | 3,600 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $227,243 | 2,922 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $238,670 | 3,096 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $266,340 | 3,256 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||